Association between migraine and the G1246A polymorphism in the hypocretin receptor 2 gene

被引:13
作者
Schuerks, Markus
Limmroth, Volker
Geissler, Ingrid
Tessmann, Grietje
Savidou, Irini
Engelbergs, Joerg
Kurth, Tobias
Diener, Hans-Christoph
Rosskopf, Dieter
机构
[1] Univ Duisburg Essen, Dept Neurol, Essen, Germany
[2] Cologne City Hosp, Dept Neurol, Cologne, Germany
[3] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Prevent Med & Aging, Boston, MA 02115 USA
[4] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[5] Ernst Moritz Arndt Univ Greifswald, Inst Pharmacol, Univ Hosp, Res Ctr Pharmacol & Expt Therapeut, Greifswald, Germany
来源
HEADACHE | 2007年 / 47卷 / 08期
关键词
migraine; hypocretin system; HCRTR2; polymorphism; association;
D O I
10.1111/j.1526-4610.2007.00863.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background.-The hypocretin receptor 2 (HCRTR2) G1246A polymorphism has been associated with the risk for cluster headache. Since the hypothalamic hypocretin/orexin system projects throughout the nervous system and affects multiple vegetative functions including generation of rhythmicity, vasomotion, autonomic symptoms as well as modulation of nociception, it may also be linked with migraine. Objective.-We thus sought to evaluate whether the HCRTR2 G1246A polymorphism is associated with the risk for migraine. Methods.-We prospectively established a cohort of 146 unrelated patients with migraine. The control group consisted of 279 healthy volunteers. We genotyped patients and controls for the HCRTR2 G1246A polymorphism and examined an association with presence or absence of migraine. Results.-Genotype and allele frequencies were not significantly different between migraine patients and controls (genotype distribution: chi(2) = 4.13, 2 df, P = .13; allele distribution: chi(2) = 0.9, 1 df, P =.34). Conclusion.-Our study does not support a major contribution of the HCRTR2 G1246A polymorphism to the pathogenesis of migraine in contrast to its effects in cluster headache.
引用
收藏
页码:1195 / 1199
页数:5
相关论文
共 29 条
[1]   Brainstem activation specific to migraine headache [J].
Bahra, A ;
Matharu, MS ;
Buchel, C ;
Frackowiak, RSJ ;
Goadsby, PJ .
LANCET, 2001, 357 (9261) :1016-1017
[2]   Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area [J].
Bartsch, T ;
Levy, MJ ;
Knight, YE ;
Goadsby, PJ .
PAIN, 2004, 109 (03) :367-378
[3]   Hypocretins (orexins) and sleep-wake disorders [J].
Baumann, CR ;
Bassetti, CL .
LANCET NEUROLOGY, 2005, 4 (10) :673-682
[4]   A genome-wide scan and HCRTR2 candidate gene analysis in a European cluster headache cohort [J].
Baumber, L. ;
Sjostrand, C. ;
Leone, M. ;
Harty, H. ;
Bussone, G. ;
Hillert, J. ;
Trembath, R. C. ;
Russell, M. B. .
NEUROLOGY, 2006, 66 (12) :1888-1893
[5]   Orexin-A, an hypothalamic peptide with analgesic properties [J].
Bingham, S ;
Davey, PT ;
Babbs, AJ ;
Irving, EA ;
Sammons, MJ ;
Wyles, M ;
Jeffrey, P ;
Cutler, L ;
Riba, I ;
Johns, A ;
Porter, RA ;
Upton, N ;
Hunter, AJ ;
Parsons, AA .
PAIN, 2001, 92 (1-2) :81-90
[6]   Genetic association studies - Genes in search of diseases [J].
Bird, TD ;
Jarvik, GP ;
Wood, NW .
NEUROLOGY, 2001, 57 (07) :1153-1154
[7]   Increased frequency of migraine in narcoleptic patients [J].
Dahmen, N ;
Querings, K ;
Grün, B ;
Bierbrauer, J .
NEUROLOGY, 1999, 52 (06) :1291-1293
[8]   Increased frequency of migraine in narcoleptic patients: a confirmatory study [J].
Dahmen, N ;
Kasten, M ;
Wieczorek, S ;
Gencik, M ;
Epplen, JT ;
Ullrich, B .
CEPHALALGIA, 2003, 23 (01) :14-19
[9]   The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity [J].
De Lecea, L ;
Kilduff, TS ;
Peyron, C ;
Gao, XB ;
Foye, PE ;
Danielson, PE ;
Fukuhara, C ;
Battenberg, ELF ;
Gautvik, VT ;
Bartlett, FS ;
Frankel, WN ;
van den Pol, AN ;
Bloom, FE ;
Gautvik, KM ;
Sutcliffe, JG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (01) :322-327
[10]   Hypocretin-1 (orexin-A) facilitates inhibitory and diminishes excitatory synaptic pathways to cardiac vagal neurons in the nucleus ambiguus [J].
Dergacheva, O ;
Wang, X ;
Huang, ZG ;
Bouairi, E ;
Stephens, C ;
Gorini, C ;
Mendelowitz, D .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 314 (03) :1322-1327